• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » A Novel Treatment for Dramatic-Onset Autoimmune OCD or Severe Food ­Restriction?

A Novel Treatment for Dramatic-Onset Autoimmune OCD or Severe Food ­Restriction?

October 18, 2021
Susan Siegfreid, MD.
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Susan Siegfreid, MD. Dr. Siegfreid has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

REVIEW OF: Melamed I et al, J Child Adolesc Psychopharmacol 2021;31(2):118–128.

Pediatric acute-onset neuropsychiatric syndrome (PANS) is defined by dramatic, abrupt onset of obsessions, compulsions, and/or eating restrictions along with two neuropsychiatric symptoms, most commonly tics, anxiety disorders, urinary difficulties, and oppositional behavior. Because PANS is thought to be an autoimmune disease, researchers have used IV immunoglobulin therapy (IVIG) as a treatment. This study tested an extended IVIG dosing strategy.

Twenty-one patients, 4–16 years old and diagnosed with moderate to severe PANS symptoms on the Pediatric Acute Neuropsychiatric Symptom Scale, were recruited from seven sites. Participants could remain on concurrent prophylactic antibiotics if doses were stable for the prior three months. Most of the patients were male (62%) with mean PANS symptom duration of 4.3 years. Participants received a total of six infusions of 1 g/kg (Octagam 5%) given every three weeks over 18 weeks.

Primary outcome measures included the Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS), Clinical Global Impressions Scale (CGI-S), and Yale Global Tic Severity Scale (YGTSS) measured at baseline and at one week and eight weeks after the last infusion. The Parent-Rated PANS Questionnaire (PRPQ), developed specifically for this study, captured interim efficacy data at each infusion visit. A subset of patients participated in a 46-week follow-up visit. Patient diaries tracked adverse events.

The IVIG infusions were effective. All primary outcome measures decreased significantly. Scores on CY-BOCS fell by 61.45% (p < 0.0002), CGI-S by 44% (p < 0.0001), and YGTSS by 66.61% (p = 0.0005). Scores on PRPQ did not improve until the third infusion but dropped 52.82% (p = 0.004) from baseline to last infusion. At 46-week follow-up, most improvements persisted except for tics; however, tic severity remained below baseline measures. The treatment was well tolerated; side effects were transient and mild and included post-infusion headache, nausea, and vomiting.

CCPR’S Take:
While the results are promising, this was a small, uncontrolled, open-label trial, and the lack of a control group precludes measuring an effect size. Still, sequential infusion of IVIG seems safe and might be effective in patients with moderate to severe PANS who do not respond to standard therapies.
Child Psychiatry
KEYWORDS anxiety-disorders compulsions eating-restriction extended-dosing iv-immunoglobulin-therapy-ivig obsessions oppositional-behavior pediatric-acute-onset-neuropsychiatric-syndrome-pans pediatric-autoimmune-neurologic-disorder-associated-with-streptococcus-pandas tics urinary-difficulties
    Susan Siegfreid, MD.

    Are Individuals With Major Depressive Symptoms More Likely to Own a Gun in the United States?

    More from this author
    www.thecarlatreport.com
    Issue Date: October 18, 2021
    SUBSCRIBE NOW
    Table Of Contents
    CME Post-Test - Overarousal in Children and Adolescents, CCPR, October/November/December 2021
    Assessing Bipolar Disorder in Children and Adolescents
    Unpacking Aggression Associated with ADHD
    Tools to Help Kids and Teens to Sleep Better
    Using Equine-Assisted Psychotherapy
    Dash Diet for Childhood ADHD
    Quetiapine vs First-Generation Antipsychotics for Aggression
    Self-Harm in Adolescents With ADHD
    A Novel Treatment for Dramatic-Onset Autoimmune OCD or Severe Food ­Restriction?
    Note From the Editor-in-Chief
    DOWNLOAD NOW
    Featured Book
    • PB4e_Cover2.png

      Psychiatry Practice Boosters, Fourth Edition (2023)

      Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.